Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 153839 |
| Drug Identification Number | 02401320 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Company Name | TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
| Strength(s) | 3G 0.375G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 3.375G VIAL |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2022-01-28 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-01-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 105 LINCOLN AVE BUENA, NEW JERSEY UNITED STATES 08310 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2022-01-29 | English | Compare |
| v2 | 2022-01-28 | French | Compare |
| v1 | 2022-01-28 | English | Compare |
Showing 1 to 3 of 3